Navigation Links
China Biologic Products Responds to Allegations on Financial Websites
Date:1/27/2010

TAI'AN, China, Jan. 27 /PRNewswire-Asia-FirstCall/ -- China Biologic Products, Inc. (Nasdaq: CBPO) ("China Biologic," or the "Company"), one of the leading plasma-based biopharmaceutical companies in China, today responded to allegations regarding the Company, certain members of its Board of Directors and a significant employee in an article that appeared on several online financial websites.

The article, which was written by an investor who disclosed a short position in the Company, highlighted the circumstances surrounding a RMB20 million loan from one of the Company's founding shareholders, Beijing Chen Da Scientific Investment Co, to Dr. Zuying Du, the transfer of Dr. Du's 25% equity ownership of the Company's predecessor, Shangdong Missile Biological Products Co., and allegations of fraud and criminal activity by Mr. Tung Lam, CEO of the Company's primary operating subsidiary, Shandong Taibang, and by the husband of the Company's director, Ms. Li Lin Ling, occurring prior to 2005. The article also included references to what are purported to be official documents supporting the allegations.

The circumstances surrounding the Company's formation, including the various legal proceedings have been disclosed in the Company's public filings with the US Securities and Exchange Commission ("SEC"). In particular, the legality of the equity transfer among the original founders has been confirmed by various PRC courts and has withstood several appeals by Dr. Du. Furthermore, in early 2007, the Company engaged Control Risks Group, a private risk consultancy firm specializing in investigative serv
'/>"/>

SOURCE China Biologic Products, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. China Yongxin Pharmaceuticals Plans to Open Eighteen New Stores in 2010 to Further Expand Customer Base and Increase Market Share
2. China YCT International Group, Inc. Announces That the State Intellectual Property Office of the Peoples Republic of China has Approved a Patent to its Operating Subsidiary, Shandong Spring Pharmaceutical Co. Ltd.
3. China Yongxin Pharmaceuticals Opened Three New Stores in 2009 and Expanded Customer Base
4. China Yongxin Pharmaceuticals Projects Higher Net Income and EPS on Reduced Revenue for Full-Year 2009
5. China Cord Blood Corporation Announces Partial Exercise of Over-Allotment Option
6. Sinovacs CEO Weidong Yin Presented with Annual Innovation Award by China Central Television
7. American Oriental Bioengineering Announces the Inclusion of 158 Drugs in Chinas National Insurance Catalog
8. China Sky Medical, Inc. Has 30 Medicines that will Be Included in Chinas National Insurance Directory
9. China Biologic Products to Ring NASDAQ Opening Bell
10. Simcere Announces 105 Drugs Included in Chinas National Drug Reimbursement List
11. Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... sophisticated equipment, trained personnel, and detection dogs to ... attacks. A revolutionary new electronic chip with nano-sized ... much easier. , The groundbreaking nanotechnology-inspired sensor, devised ... ,s School of Chemistry and Center for Nanoscience ... Tracense, picks up the scent of explosives molecules ...
(Date:7/24/2014)... , July 24, 2014 Research and ... "Global Cell Culture Market 2014-2018" report to their ... Cell culture is the in vitro growth of ... research, cell studies, and biopharmaceutical production. Cell culture is ... Cell culture instruments and cell culture consumables are necessary ...
(Date:7/24/2014)... (PRWEB) July 24, 2014 Three companies ... semi-finalists in Livestrong’s Big C Competition. Out of 700 ... each headed to the semi-final round. In this round ... three-month accelerator program, complete with mentoring from thought-leaders and ... As part of the angelMD commitment to the Livestrong ...
(Date:7/24/2014)... The first part of the session on ... Human Studies” will cover comprehensive clinical support in early ... increasing R&D costs and declining industry success in getting ... knowledge collected in early Phase I/IIa study data to ... stage development. , Next, the presenters will examine steps ...
Breaking Biology Technology:Nano-sized chip 'sniffs out' explosives far better than trained dogs 2Global Cell Culture Market 2014-2018: Key Vendors are Becton, Dickinson and Co, EMD, GE Healthcare, Lonza Group, Sigma Aldrich and Thermo Fisher Scientific 23 angelMD Startups Make Livestrong Big C Semi-finals 2Best Practices for Optimizing Dose Escalation in First in Human Studies, New Webinar August 6th Hosted by Xtalks 2
... Arena Pharmaceuticals,Inc. (Nasdaq: ARNA ) announced today ... Stearns 20th Annual Healthcare Conference on September,11, 2007 at ... the Grand,Hyatt Hotel in New York City. Jack Lief, ... a corporate overview of the,company and its clinical development ...
... Vical Incorporated,(Nasdaq: VICL ) today announced ... Conference will be webcast live on Monday, September ... and Chief Executive Officer,Vijay B. Samant, will provide ... strategic partnerships. The webcast will be,available live and ...
... ... 2007--, PALO ALTO, Calif., ... data published in Circulation and,presented at the European Society of Cardiology Congress ... atrial arrhythmias in patients receiving Ranexa,compared to placebo in the MERLIN TIMI-36 ...
Cached Biology Technology:Arena Pharmaceuticals to Present at the Bear Stearns 20th Annual Healthcare Conference 2Arena Pharmaceuticals to Present at the Bear Stearns 20th Annual Healthcare Conference 3Vical to Present at Upcoming Investor Conferences 2Circulation Publishes MERLIN TIMI-36 Data Showing Safety and Anti-Arrhythmic Effects of Ranexa(R) 2Circulation Publishes MERLIN TIMI-36 Data Showing Safety and Anti-Arrhythmic Effects of Ranexa(R) 3Circulation Publishes MERLIN TIMI-36 Data Showing Safety and Anti-Arrhythmic Effects of Ranexa(R) 4
(Date:7/25/2014)... the way for the development of new lines of barley ... production is second only to wheat with 7-8 million tonnes ... diseases of barley. , Senior Research Scientist Dr Alan Little ... the cell walls of barley plants that block the penetration ... the ARC Centre of Excellence in Plant Cell Walls in ...
(Date:7/25/2014)... MOResearchers at the Stowers Institute for Medical Research ... pheromone receptors, and found pheromones crucial to triggering the ... of receptors helps a male mouse detect pheromones that ... of receptors lets him know if the female mouse ... pheromones are critical to trigger mating. Stowers, researchers believe ...
(Date:7/24/2014)... leads to conflict among people around the world, a ... Health & Ecosystems: Analysis of Linkages (HEAL) Program Director ... tackle global biodiversity decline. , The harvest of wild ... and provides protein for more than a billion of ... that today,s unprecedented loss of wildlife, is bringing with ...
Breaking Biology News(10 mins):New hope for powdery mildew resistant barley 2It takes two to court 2It takes two to court 3New study draws links between wildlife loss and social conflicts 2
... (December 2nd, 2011) Most of us would agree that ... the journal Clinical Rehabilitation , published by SAGE, indicate ... on health grounds in Finland had no measurable effect. , ... rehabilitation, which followed 872 participants and their 2440 matched controls ...
... research hurdle to developing regenerative treatments for diabetes and ... amounts of endoderm cells from human pluripotent stem cells. ... can be transferred to other areas of stem cell ... use known as the ,valley of death,. "One ...
... implantable replacement cartilage, holding promise for knees, shoulders, ears ... Self-assembling sheets of mesenchymal stem cells permeated ... stiffer cartilage than previous tissue engineering methods, researchers at ... the research is published in the Journal of ...
Cached Biology News:Costly intervention program has no measurable effect on early retirement 2Costly intervention program has no measurable effect on early retirement 3Scalable amounts of liver and pancreas precursor cells created using new stem cell production method 2Engineering cartilage replacements 2Engineering cartilage replacements 3